Our ALKtALK replay on Empowering Wellness w/ Dr Narjust Florez, MD, FASCO is now available.

We discuss the big issues across our community. In this snippet, Dr Florez shares the industry discussion on finding effective doses over maximum tolerated ones.

📺youtu.be/fxtLVrfAUrQ?si… #LCSM

We had an an amazing ALKtALK with the one and only Dr Narjust Florez, MD, FASCO. We spanned all the vital topics - from weight gain, relationships, sexual health & more.

We'll be sharing our replay shortly. Here's a behind the scenes shot with our co-hosts Summer, Yvonne & Dana. #LCSM

Happy International #ClinicalTrials Day. A #clinicaltrial didn’t just save my life…it gave me life! Thanks to #clinicaltrial s I have laughed, I have cried, I have loved, I have dreamed, but most of all I have nurtured my babies and been present as their mum. #lungcancer #lcsm

Lung cancer has many faces! Each person's journey is unique #Cancersurvivorship ALK Positive ALK+ International Yvonne Diaz Narjust Florez, MD, FASCO

This is a BIG DEAL for those living with small cell #lungcancer . Using 'targeted immunotherapy' that tethers the cancer cell and a T cell (a type of immune cell), you can cause the cancer cell to burst. This is a new era for how researchers are approaching this and other cancers.

Tune into tonight at 6pm ET for our next ALKtALK with Dr Narjust Florez, MD, FASCO

Many of us with ALK+ cancer grapple with various issues - from side effects, family, palliative care and more. Come join us as we discuss everything around empowering wellness.

👉 alkpositive.org/alktalk

Looking for get involved in #Cancersupport advocacy? We're speaking about lung cancer but convo applicable to all. Join us for this live and lively discussion of advocacy across continents. IASLC ASCO, thnx Yvonne Diaz for hosting.

Fantastic news for our ALK+ #lungcancer community 🙌

The U.S. FDA has granted breakthrough therapy designation to Nuvalent's NVL-655 for the treatment of patients with locally advanced or metastatic ALK+ LC who have been previously treated 2+ TKIs.

#LCSM #ResearchSavesLives

📢 Program update: NVL-655 has received FDA breakthrough therapy designation (BTD)! This important milestone for our ALK program marks the second BTD granted to our pipeline this year.
$NUVL #NSCLC
investors.nuvalent.com/2024-05-16-Nuv…

🚨Stay tuned for the next ALKtALK session by ALK Positive. This conversation will be centered around Empowering Wellness- Navigating body image, family dynamics, sexuality & #QOL with Narjust Florez, MD, FASCO‼️

🗓️: Sunday, May 19th 2024

⌚️: 6pm ET

alkpositive.org/alktalk

Curious about #biomarkers and how they may inform treatment options for your #lungcancer ? Gene is here to share the facts! #KnowWithGene and visit #NoOneMissed to explore more on #biomarkertesting in #NSCLC : no1missed.org/3ZpfEIL

An ALK+ #cancer diagnosis raises many questions, like: how we can live as well as possible? How do we manage everything from side effects to family & relationships?

Our next ALKtALK will explore these questions w Dr Narjust Florez, MD, FASCO at 6pm ET on Sunday 👇 alkpositive.org/alktalk

Amazing, I love this!
How I long to be in this club- and then again, and again, and again. 🤍🤍
Gooo science! #MoreResearchMoreLife

Every year since 2018 we have gathered 5 or more year survivors of lung cancer together at CU to show others that hope has a face. This is the May 11th 2024 gathering. Rock on!

Seeing more and more 5+ year survival for #lungcancer is the very definition of hope and why research matters.

There is a very special place in all our hearts for those who devote themselves to improving lung cancer care, research and outcomes. Thank you 🤍

#LCSM #Hope

ALK-positive #lungcancer community:

Worth tuning into this IASLC podcast presenting data from the ALINA #clinicaltrial which has identified practice changing treatment strategies for earlier stage ALK-positive #lungcancer .

Thanks Drs. Narjust Florez, MD, FASCO and Ben Solomon
#LCSM

🚨📝 A pragmatic guide for management of adverse events associated with lorlatinib
Link here 👉lungcancerjournal.info/article/S0169-…

#LCSM ALK Positive

What is the minimally effective dose of our #cancer treatments? Patients have been asking this question and now the US FDA is too.

Read more about Project Optimus, in which the agency is doing something about dosage guidelines for future drugs.

apple.news/AipNSaIEyQQGRO…

#LCSM

🎙️Episode 2 of ⁦@OBRtweets⁩ “Leading Thoughts in Lung Cancer” is out!

Join the conversation as ⁦⁦Sandip Patel MD⁩, Maya K. Khalil, MD⁩ & myself discuss the role of targeted therapy in the management of early-stage resectable NSCLC #lcsm
obroncology.com/leading-though…

ALK Positive Break Through Cancer alkpositivebelgium ALK Positive Australia Inc. alk ros1 france cancer poumon Jesse Boehm Johns Hopkins University MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Dana-Farber Persister cells are a big concern across our oncogene-driven #lungcancers . Incredible to see a large project like this devoted to this issue - congrats ALK Positive and Break Through Cancer 👏👏👏. This shows how a patient-led community can drive #research 🩵